BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31676661)

  • 1. Prognostic factors for relapse in patients with clinical stage I testicular cancer: protocol for a Danish nationwide cohort study.
    Wagner T; Toft BG; Engvad B; Lauritsen J; Kreiberg M; Bandak M; Rosenvilde J; Christensen IJ; Pilt AP; Berney D; Daugaard G
    BMJ Open; 2019 Oct; 9(10):e033713. PubMed ID: 31676661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late Relapses in Stage I Testicular Cancer Patients on Surveillance.
    Mortensen MS; Lauritsen J; Kier MG; Bandak M; Appelt AL; Agerbæk M; Holm NV; Kempel MM; von der Maase H; Daugaard G
    Eur Urol; 2016 Aug; 70(2):365-71. PubMed ID: 26996661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Factors for Relapse in Patients With Clinical Stage I Testicular Seminoma: A Nationwide, Population-Based Cohort Study.
    Wagner T; Toft BG; Lauritsen J; Bandak M; Christensen IJ; Engvad B; Kreiberg M; Agerbæk M; Dysager L; Rosenvilde JJ; Berney D; Daugaard G
    J Clin Oncol; 2024 Jan; 42(1):81-89. PubMed ID: 37683134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors for relapse in patients with clinical stage I testicular non-seminoma: A nationwide, population-based cohort study.
    Wagner T; Toft BG; Lauritsen J; Bandak M; Christensen IJ; Engvad B; Kreiberg M; Agerbæk M; Dysager L; Carus A; Rosenvilde JJ; Berney D; Daugaard G
    Eur J Cancer; 2024 May; 202():114025. PubMed ID: 38531266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis.
    Warde P; Specht L; Horwich A; Oliver T; Panzarella T; Gospodarowicz M; von der Maase H
    J Clin Oncol; 2002 Nov; 20(22):4448-52. PubMed ID: 12431967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nationwide cohort study of stage I seminoma patients followed on a surveillance program.
    Mortensen MS; Lauritsen J; Gundgaard MG; Agerbæk M; Holm NV; Christensen IJ; von der Maase H; Daugaard G
    Eur Urol; 2014 Dec; 66(6):1172-8. PubMed ID: 25064686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for tumor recurrence in patients with clinical stage I seminoma undergoing surveillance--protocol for a systematic review.
    Kunath F; Spek A; Jensen K; Zengerling F; Schmidt S
    Syst Rev; 2015 Dec; 4():182. PubMed ID: 26684760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surveillance of stage I testicular seminoma: 20 years oncological results].
    Zores T; Mouracade P; Duclos B; Saussine C; Lang H; Jacqmin D
    Prog Urol; 2015 Apr; 25(5):282-7. PubMed ID: 25724863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
    Rothermundt C; Thurneysen C; Cathomas R; Müller B; Mingrone W; Hirschi-Blickenstorfer A; Wehrhahn T; Ruf C; Rothschild S; Seifert B; Terbuch A; Grassmugg T; Woelky R; Fankhauser C; Kunit T; Fischer N; Inauen R; Kamradt J; Ziegler K; Haynes A; Jüni P; Gillessen S
    Swiss Med Wkly; 2018; 148():w14640. PubMed ID: 30044478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage I testicular seminoma: results of adjuvant irradiation and surveillance.
    Warde P; Gospodarowicz MK; Panzarella T; Catton CN; Sturgeon JF; Moore M; Goodman P; Jewett MA
    J Clin Oncol; 1995 Sep; 13(9):2255-62. PubMed ID: 7666083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for relapse in stage I testicular seminoma treated with surveillance.
    Warde P; Gospodarowicz MK; Banerjee D; Panzarella T; Sugar L; Catton CN; Sturgeon JF; Moore M; Jewett MA
    J Urol; 1997 May; 157(5):1705-9; discussion 1709-10. PubMed ID: 9112510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditional Risk of Relapse in Surveillance for Clinical Stage I Testicular Cancer.
    Nayan M; Jewett MA; Hosni A; Anson-Cartwright L; Bedard PL; Moore M; Hansen AR; Chung P; Warde P; Sweet J; O'Malley M; Atenafu EG; Hamilton RJ
    Eur Urol; 2017 Jan; 71(1):120-127. PubMed ID: 27527805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of care and survival outcomes for adolescent and young adult patients with testicular seminoma in the United States: A National Cancer Database analysis.
    Stokes W; Amini A; Maroni PD; Kessler ER; Stokes C; Cost CR; Greffe BS; Garrington TP; Liu AK; Cost NG
    J Pediatr Urol; 2017 Aug; 13(4):386.e1-386.e7. PubMed ID: 28153774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance.
    Chung P; Daugaard G; Tyldesley S; Atenafu EG; Panzarella T; Kollmannsberger C; Warde P
    Cancer Med; 2015 Jan; 4(1):155-60. PubMed ID: 25236854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma.
    Fischer S; Tandstad T; Wheater M; Porfiri E; Fléchon A; Aparicio J; Klingbiel D; Skrbinc B; Basso U; Shamash J; Lorch A; Dieckmann KP; Cohn-Cedermark G; Ståhl O; Chau C; Arriola E; Marti K; Hutton P; Laguerre B; Maroto P; Beyer J; Gillessen S
    J Clin Oncol; 2017 Jan; 35(2):194-200. PubMed ID: 27893332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
    Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
    Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort.
    Daugaard G; Gundgaard MG; Mortensen MS; Agerbæk M; Holm NV; Rørth M; von der Maase H; Christensen IJ; Lauritsen J
    J Clin Oncol; 2014 Dec; 32(34):3817-23. PubMed ID: 25267754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and outcomes of clinical stage IIA/B seminoma: Results from the National Cancer Data Base 1998-2012.
    Paly JJ; Lin CC; Gray PJ; Hallemeier CL; Beard C; Sineshaw H; Jemal A; Efstathiou JA
    Pract Radiat Oncol; 2016; 6(6):e249-e258. PubMed ID: 27345128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology.
    Bilici A; Ozturk T; Turkmen E; Odabas H; Cihan S; Selcukbiricik F; Erdogan B; Urakci Z; Kandemir N; Bayoglu IV; Demirci U; Duran AO; Sendur MA; Yavuzer D; Harputluoglu H; Kavgaci H; Gumus M
    World J Urol; 2015 Oct; 33(10):1613-22. PubMed ID: 25605506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
    Hosni A; Warde P; Jewett M; Bedard P; Hamilton R; Moore M; Nayan M; Huang R; Atenafu EG; O'Malley M; Sweet J; Chung P
    Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):648-54. PubMed ID: 27339401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.